Sort
53,477 grants matching “addiction”
Implementation of Technology-Based Evaluation of Motivational Interviewing
$647,176David Charles Atkins · University Of Washington · R01 · FY2016 · AA
A Reduced Complexity Cross in BALB/c substrains to identify the genetic basis of oxycodone dependence phenotypes
$647,133Camron D Bryant · Boston University Medical Campus · U01 · FY2021 · DA
Multiscale Genetic Connectivity of Primate Social Circuits
$647,114Julie R Korenberg · University Of Utah · R01 · FY2015 · MH
Making connections among social ties, neural sensitivity to social signals, and outcomes
$647,092Pearl H Chiu · Virginia Polytechnic Inst And St Univ · R01 · FY2021 · AA
Medical marijuana: Longitudinal trajectories in use, pain and functioning
$647,074Mark A. Ilgen · University Of Michigan At Ann Arbor · R01 · FY2014 · DA
Melanoma Resistance Evolution Atlas (MREA) for identifying combinatorial targets to prevent and reverse MAPKi resistance
$647,072Roger S Lo · University Of California Los Angeles · R01 · FY2025 · CA
Extinction of Limbic Activation to "Unseen" Cocaine Cues
$647,060Anna Rose Childress · University Of Pennsylvania · R01 · FY2010 · DA
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
$647,023Sheela Shenoi · Yale University · R01 · FY2021 · DA
Preventing HIV among Native Americans through the treatment PTSD & substance use
$647,012Cynthia Renee Pearson · University Of Washington · R01 · FY2017 · MD
Implementation, Outcomes, and Cost of a Novel Medicaid Policy to Reduce Opioids for Back Pain
$646,926Esther K Choo · Oregon Health & Science University · R01 · FY2019 · DA
Early Life Stress and Depression: Molecular and Functional Imaging Approaches
$646,824Diego A. Pizzagalli · Mclean Hospital · R01 · FY2012 · MH
Regulation of Gene Expression in the Human Habenula in Comorbid Opioid Addiction and Depression
$646,796Kristen Rose Maynard · Lieber Institute, Inc. · R01 · FY2023 · DA
Optimizing SBIRT for Drug-Using Patients in an Inner-City Emergency Department
$646,748Frederic C Blow · University Of Michigan At Ann Arbor · R01 · FY2012 · DA
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder
$646,735Lara Ray · University Of California Los Angeles · R01 · FY2021 · AA
Analysis of a Novel Cocaine Induced Immediate Early Gene
$646,704Paul F Worley · Johns Hopkins University · R37 · FY2012 · DA
Employment-Based Depot Naltrexone Clinical Trial
$646,663Kenneth Silverman · Johns Hopkins University · R01 · FY2007 · DA
Testing Peer-led Network Intervention to Prevent Adolescent Vaping
$646,661Peter A Wyman · University Of Rochester · R01 · FY2024 · DA
NorthStar Node of the Clinical Trials Network
$646,605Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2020 · DA
Effects of Opiate on Virus/Host Responses in SHIV/Macaques
$646,603Anil Kumar · University Of Missouri Kansas City · R01 · FY2011 · DA
Informing anti-tobacco communications with affective and decision science: Application of the Appraisal Tendency Framework
$646,580Vaughan W. Rees · Harvard School Of Public Health · R01 · FY2020 · CA
Juvenile Offender HIV Prevention and Drug Abuse Services
$646,573Howard A Liddle · University Of Miami School Of Medicine · R01 · FY2011 · DA
Randomized Trial of Intensive MI to Improve Drinking Outcomes Among Women
$646,528Douglas L Polcin · Public Health Institute · R01 · FY2015 · AA
Using a Genetic Approach to Understand Factors Influencing Resistance to Substance Use
$646,517Elizabeth Chin Prom-Wormley · Virginia Commonwealth University · R01 · FY2023 · DA
Sex differences in stress inoculation of addiction-like phenotypes
$646,493Debra A Bangasser · Temple Univ Of The Commonwealth · R01 · FY2022 · DA
Sex differences in stress inoculation of addiction-like phenotypes
$646,493Debra A Bangasser · Temple Univ Of The Commonwealth · R01 · FY2021 · DA